![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 0.11% | 4.65 | 4.41 | 4.89 | 4.53 | 4.51 | 4.53 | 241,784 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.51 | 9.35M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/7/2020 18:28 | >> guru That's not how the trial is being done so using it that way will not be on the label. And the cost would be prohibitive for using it in that manner. It's not going to happen.... | ![]() nobbygnome | |
25/7/2020 18:26 | No one knows, could be used as a preventative measure just like taking Vitamin D to boost your interferon beta levels... | ![]() guru | |
25/7/2020 18:23 | It's not a treatment for COPD itself! It's for the exacerbations caused when COPD patients have a viral respiratory infection. So you can't count the whole population because they won't all get a serious infection by any means. | ![]() nobbygnome | |
25/7/2020 18:20 | 1.2 million people x say £1000= £1.2Billion just in the UK | ![]() guru | |
25/7/2020 18:18 | The golden goose is Treatment for COPD. There are 1.2 million people living with diagnosed COPD in the UK, the second most common lung disease in the UK. | ![]() guru | |
25/7/2020 18:04 | Elsol my understanding is the value here is a lot more than just Covid! | ![]() tickboo | |
25/7/2020 17:59 | Elsol Good try but not even close. This will be a multi billion market I can see £10 a share quite easily from here and maybe £20. However there is potential for more. Perhaps not quite £100. | vikingwarrier | |
25/7/2020 17:57 | Afternoon nobbygnome, Please share some coins. Many thanks Viking Warrier | vikingwarrier | |
25/7/2020 17:46 | Elsol I agree it will be around that mark but you have not factored in the licensing deals and the ongoing recurring potential so x your estimate by 6 and you will be at 2bn | ![]() strongbuy | |
25/7/2020 17:46 | Interesting activity in New York on the OTC after we closed Friday...got a feeling Monday is going to be another very special day. | oranolio | |
25/7/2020 17:33 | Done. But you will have to up your game a bit if you make that sort of post on the Guild. There are so many glaring holes in your calculations and assumptions a London bus could drive through them..... | ![]() nobbygnome | |
25/7/2020 17:29 | Afternoon nobbygnome, Please share some coins. Much appreciated Elsol | ![]() elsol | |
25/7/2020 17:27 | this just one guess but at least it is in the ballpark! | ![]() elsol | |
25/7/2020 17:25 | Some of the value numbers floating around here are simply crazy wrong. The share price could go up more Im not saying that but the calc. for US citizens x 100GBP is wrong. You need to consider only say 5% of the population that may progress to hospital critical / severe first. so Divide by 20! then you take revenues and assume some profit say 10% because SNG will be under high pressure to keep profit reasonable and not take the PiS*. Then you have to consider that when vaccines come on stream they may reduce the market size by say 50%. So another x0.5. So approx profit for US: Hence the possible value/profit (rough guess) = £93m USA (375m x 100 x 0.05 x 0.1 x0.5) x3 including rest of world? £279m. Add 25% upside for other licensed virus uses. = total approx £350m Market cap. | ![]() elsol | |
25/7/2020 17:19 | So have you got £450 million down the back of the sofa.... | ![]() nobbygnome | |
25/7/2020 17:16 | In that case I offer £3 for the company then. Now how do I write and RNS? | vikingwarrier | |
25/7/2020 17:14 | >> sloppy joe My £5 price minimum is if there is a bid in the very short term before there are any further developments. If conditional approval comes from any regulator, then it will certainly be closer to £10 than £5! | ![]() nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions